Search Results 391-400 of 24067 for B cell lymphomas

  1. Lymphoma - Doctors and departments - Mayo Clinic

    Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...

  2. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    High-grade BCL with MYC and B-cell lymphoma 2 (BCL2) and/or B-cell lymphoma 6 (BCL6) rearrangements (double-hit or triple-hit lymphoma). Please note ...

  3. Hematology - Clinical trials

    ... cell lymphoma that has come back or does not respond to treatment. ... A virus, called VSV-hIFNbeta-NIS, which has been changed in a certain way, may be able to ...

  4. James R. Cerhan, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    B-Cell Lymphoproliferative Disorders: Susan L. Slager · Lymphoma Epidemiology: James R. Cerhan · Quantitative Health Sciences · Mayo Clinic Biobank ...

  5. Clinical trials - Oncology (Medical)

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  6. Night sweats Causes - Mayo Clinic

    In-depth. Anaplastic large cell lymphoma · B-cell lymphoma · Burkitt lymphoma · Cancer · Castleman disease · Chronic lymphocytic leukemia.

  7. Mantle cell lymphoma - Doctors and departments - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

  8. T Cell Engineering Laboratory - Research Team

    Her research focus is understanding the mechanism of action of CAR-T cells as a targeted cellular therapy to improve their efficacy in B-cell lymphomas. In ...

  9. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL - Mayo Clinic

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  10. Polatuzumab vedotin-piiq (intravenous route) - Side effects & uses - Mayo Clinic

    Polatuzumab vedotin-piiq injection is used together with other cancer medicines (eg, bendamustine, rituximab) to treat diffuse large B-cell lymphoma (DLBCL) ...